Anti-Amyloids for Alzheimer’s

Zhelnov P. A critical appraisal of ‘Lu L, Zheng X, Wang S, Tang C, Zhang Y, Yao G, Zeng J, Ge S, Wen H, Xu M, Guyatt G, Xu N. Anti-Aβ agents for mild to moderate Alzheimer’s disease: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2020 Oct 12:jnnp-2020-323497. doi: 10.1136/jnnp-2020-323497. Epub ahead of print. PMID: 33046560’. Zheln. 2020 Oct 14;42(2):r116d14. URI: https://zheln.com/record/2020/10/14/116/.

Zheln Review Appraisal in 10 Steps:

1. ✅ Downloaded from the PubMed Systematic Subset Daily Updates
2. ✅ Meets Shojania & Bero 2001 True Positive Criteria for Systematic Reviews by Title
3. ❌ No Full Text Available to Zheln
4. 🔄 Generates Pragmatic Evidence Directly Relevant to Evidence-Based Practice?
5. 🔄 Is Duplicate?
6. 🔄 Passed or Failed Replication?
7. 🔄 Has Critical Conduct Flaws?
8. 🔄 Liked or Disliked by Zheln?
9. 🔄 Practical Implications Summarized by Zheln
10. 🔄 Appraisal Published & Call for Crowdfunding

I have already looked at this record but could not advance further as I’m unable to collect the study reports required for this appraisal. Therefore, this appraisal is on the waitlist until the report collection is crowdfunded.

If you have these study reports at hand and would like to share them with me, I greatly appreciate your concern. Please contact me by email or on Twitter, Facebook, Instagram, or Telegram.

As such, this project is independent research and is supported by crowdfunding only, so please also consider making a minimal donation as low as $1 either on Patreon or via PayPal. Thank you! ❤️